UCB SA (UCB-BT)

QUOTE AND NEWS
StreetInsider.com  Sep 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amgen+%28AMGN%29%2C+UCB+Present+Data+from+Romosozumab+Phase+2+in+Postmenopausal+Women+with+Low+BMD/9832979.html for the full story.
FiercePharma  Sep 12  Comment 
The threat of action from lawmakers may have put a damper on pharma's tax inversion frenzy, but it has not stopped the wave of deals that are taking American drugmakers overseas. Next up could be Illinois' Akorn, which is reportedly looking into a...
Reuters  Sep 11  Comment 
U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a...
SeekingAlpha  Aug 8  Comment 
This week’s patent expirations are related to UCB’s (OTCPK:UCBJF) Vimpat, a seizure medication, and Genentech’s [now owned by Roche (OTCQX:RHHBY)] Nutropin Depot. Vimpat Vimpat launched in 2009 as an...
FiercePharma  Aug 6  Comment 
Shedding noncore assets is the trend du jour in Big Pharma, and now another company may be jumping on the bandwagon. Belgium's UCB is reportedly looking into a sale of Kremers Urban Pharmaceuticals, its Princeton, NJ-based generics unit.
Reuters  Aug 5  Comment 
Belgian pharmaceutical company UCB is exploring a sale of its Kremers Urban Pharmaceuticals Inc division, a U.S. specialty generics business that could fetch as much as $2...
SeekingAlpha  Jul 30  Comment 
UCB S.A. (OTCPK:UCBJF) Q2 2014 Results Earnings Conference Call July 30, 2014, 08:00 AM ET Executives Roch Doliveux - CEO Jean-Christophe Tellier - CEO-Elect Detlef Thielgen - EVP and CFO Analysts Richard Park - Deutsche...
FierceBiotech  Jul 23  Comment 
A new epilepsy treatment from Belgian drugmaker UCB helped reduce the rate of seizures in a Phase III trial, the company said, setting the stage for an FDA application and a shot at widening its footprint in the field.
Cloud Computing  Jul 7  Comment 
Infotrieve, Inc. (www.infotrieve.com), the leader in global-enterprise SaaS software and business services for scientific, technical and medical (“STM”) published content access and management, today announced that it has...





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki